160 related articles for article (PubMed ID: 15464655)
1. Iron, the HFE gene, and hepatitis C.
Eisenbach C; Gehrke SG; Stremmel W
Clin Liver Dis; 2004 Nov; 8(4):775-85, vii-viii. PubMed ID: 15464655
[TBL] [Abstract][Full Text] [Related]
2. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C, iron status, and disease severity: relationship with HFE mutations.
Tung BY; Emond MJ; Bronner MP; Raaka SD; Cotler SJ; Kowdley KV
Gastroenterology; 2003 Feb; 124(2):318-26. PubMed ID: 12557137
[TBL] [Abstract][Full Text] [Related]
4. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.
Smith BC; Gorve J; Guzail MA; Day CP; Daly AK; Burt AD; Bassendine MF
Hepatology; 1998 Jun; 27(6):1695-9. PubMed ID: 9620344
[TBL] [Abstract][Full Text] [Related]
5. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
[TBL] [Abstract][Full Text] [Related]
6. Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
Bonkovsky HL; Naishadham D; Lambrecht RW; Chung RT; Hoefs JC; Nash SR; Rogers TE; Banner BF; Sterling RK; Donovan JA; Fontana RJ; Di Bisceglie AM; Ghany MG; Morishima C;
Gastroenterology; 2006 Nov; 131(5):1440-51. PubMed ID: 17101320
[TBL] [Abstract][Full Text] [Related]
7. [Iron as comorbid factor in chronic hepatitis C].
Erhardt A; Hauck K; Häussinger D
Med Klin (Munich); 2003 Dec; 98(12):685-91. PubMed ID: 14685669
[TBL] [Abstract][Full Text] [Related]
8. Could iron deposits in hepatocytes serve as a prognostic marker of HFE gene mutations?
Sikorska K; Stalke P; Jaskiewicz K; Romanowski T; Bielawski KP
Hepatogastroenterology; 2008; 55(84):1024-8. PubMed ID: 18705322
[TBL] [Abstract][Full Text] [Related]
9. Role of hemochromatosis genes in chronic hepatitis C.
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R; Baldassarre R
Clin Ter; 2006; 157(1):61-8. PubMed ID: 16669553
[TBL] [Abstract][Full Text] [Related]
10. Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C.
Bonkovsky HL; Troy N; McNeal K; Banner BF; Sharma A; Obando J; Mehta S; Koff RS; Liu Q; Hsieh CC
J Hepatol; 2002 Dec; 37(6):848-54. PubMed ID: 12445428
[TBL] [Abstract][Full Text] [Related]
11. Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C.
Sikorska K; Stalke P; Romanowski T; Rzepko R; Bielawski KP
Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):377-84. PubMed ID: 23924495
[TBL] [Abstract][Full Text] [Related]
12. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
[TBL] [Abstract][Full Text] [Related]
13. Marked iron in liver explants in the absence of major hereditary hemochromatosis gene defects: a risk factor for cardiac failure.
Fenton H; Torbenson M; Vivekanandan P; Yeh MM; Hart J; Ferrell L
Transplantation; 2009 Apr; 87(8):1256-60. PubMed ID: 19384175
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma.
Fargion S; Stazi MA; Fracanzani AL; Mattioli M; Sampietro M; Tavazzi D; Bertelli C; Patriarca V; Mariani C; Fiorelli G
Blood Cells Mol Dis; 2001; 27(2):505-11. PubMed ID: 11500061
[TBL] [Abstract][Full Text] [Related]
15. Co-factors in liver disease: the role of HFE-related hereditary hemochromatosis and iron.
Wallace DF; Subramaniam VN
Biochim Biophys Acta; 2009 Jul; 1790(7):663-70. PubMed ID: 18848602
[TBL] [Abstract][Full Text] [Related]
16. Iron accumulation in chronic hepatitis C: relation of hepatic iron distribution, HFE genotype, and disease course.
Corengia C; Galimberti S; Bovo G; Vergani A; Arosio C; Mariani R; Redaelli A; Riva A; Cestari C; Pozzi M; Valsecchi MG; Piperno A
Am J Clin Pathol; 2005 Dec; 124(6):846-53. PubMed ID: 16416733
[TBL] [Abstract][Full Text] [Related]
17. Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.
Fracanzani AL; Fargion S; Stazi MA; Valenti L; Amoroso P; Cariani E; Sangiovanni A; Tommasini M; Rossini A; Bertelli C; Fatta E; Patriarca V; Brescianini S; Stroffolini T
Blood Cells Mol Dis; 2005; 35(1):27-32. PubMed ID: 15894495
[TBL] [Abstract][Full Text] [Related]
18. [Hereditary and acquired iron overload].
de Korwin JD
Nephrol Ther; 2006 Nov; 2 Suppl 5():S304-12. PubMed ID: 17373275
[TBL] [Abstract][Full Text] [Related]
19. Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation, and HFE missense mutations.
Pirisi M; Scott CA; Avellini C; Toniutto P; Fabris C; Soardo G; Beltrami CA; Bartoli E
Am J Clin Pathol; 2000 Apr; 113(4):546-54. PubMed ID: 10761457
[TBL] [Abstract][Full Text] [Related]
20. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]